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Background
Currently, left ventricular dysfunction derived from
echocardiography is the main basis for determining elig-
ibility of patients for implantable cardioverter-defibrilla-
tor (ICD) placement in the primary prevention of
sudden cardiac death (SCD). However, recent trials sug-
gest that approximately 14 to 18 patients with ventricu-
lar dysfunction need to have an ICD implanted to
prevent 1 death. Given the substantial cost and potential
for complications, improved risk stratification to identify
patients who would benefit most from ICD implantation
remains an important public health challenge. Cardiac
magnetic resonance imaging (CMR) is the current gold
standard for measurement of left ventricular ejection
fraction (LVEF). We hypothesized that using LVEF
derived from CMR compared with echocardiography
may lead to a significant impact on ICD implantation
rates which could translate into improved selection of
patients and possible cost reductions.
Methods
Two hundred and eleven consecutive patients referred for
CMR with an echocardiographic diagnosis of cardiomyo-
pathy and/or an LVEF of ≤45% were prospectively
recruited. Of these, thirty-three patients were referred
specifically to determine eligibility for ICD implantation
and comprised the study population.
Results
On the basis of CMR derived LVEF, an overall change in
classification of ICD eligibility occurred in 16 patients
(48%), with 1 patient (3%) reclassified to receive an ICD
and 15 patients (45%) reclassified to avoid ICD implanta-
tion when they otherwise would have been implanted
based on echocardiographic LVEF. In 11 patients (33%),
CMR confirmed eligibility for ICD implantation as was
previously suspected, and in 6 patients (18%), CMR recon-
firmed that ICD implantation was not indicated. Use of
CMR compared to echocardiographic LVEF led to a 43%
absolute reduction in device implantation (p=0.001). None
of the patients reclassified to avoid ICD implantation
experienced SCD or sustained ventricular arrhythmias
over a mean follow-up of 24 ±15 months.
Conclusions
Among patients being considered for ICD implantation on
the basis of prior echocardiography, use of CMR derived
LVEF led to a change in ICD eligibility in 48% of cases
and resulted in a 43% absolute reduction in device implan-
tation. Moreover, none of the patients reclassified to avoid
ICD implantation experienced sudden cardiac death or
sustained ventricular arrhythmias over a mean follow-up
of 24 ±15 months. Larger prospective studies are required
to assess the safety and cost implications of these findings.
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